Allspring Global Investments
NVO

Allspring Global Investments’s Novo Nordisk NVO Stock Holding History

Allspring Global Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.22M Buy
45,558
+7,349
+19% +$316K ﹤0.01% 1049
2026
Q1 		$1.39M Buy
38,209
+7,465
+24% +$354K ﹤0.01% 1108
2025
Q4 		$1.61M Sell
30,744
-56,238
-65% -$2.88M ﹤0.01% 1067
2025
Q3 		$5.15M Sell
86,982
-7,570
-8% -$443K 0.01% 865
2025
Q2 		$6.6M Sell
94,552
-3,295
-3% -$224K 0.01% 822
2025
Q1 		$6.66M Buy
97,847
+76,994
+369% +$6.36M 0.01% 837
2024
Q4 		$1.83M Sell
20,853
-406,932
-95% -$44M ﹤0.01% 1161
2024
Q3 		$50.9M Buy
427,785
+99,945
+30% +$13.3M 0.08% 309
2024
Q2 		$46.8M Buy
327,840
+14,549
+5% +$1.93M 0.08% 319
2024
Q1 		$40.2M Buy
313,291
+33,463
+12% +$3.98M 0.06% 391
2023
Q4 		$28.9M Buy
279,828
+279,244
+47,816% +$27.6M 0.05% 467
2023
Q3 		$53.1K Hold
584
– – ﹤0.01% 2245
2023
Q2 		$47.3K Buy
+584
New +$47.7K ﹤0.01% 2306

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Allspring Global Investments's NVO Position: Q2 2026 in Review

Allspring Global Investments increased its Novo Nordisk (NVO) stake by 19% in Q2 2026, buying an estimated $316K and bringing the position to 45,558 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1049.

Allspring Global Investments first reported a position in NVO in Q2 2023 and has held it in 13 quarters since. The position peaked at $50.9M in Q3 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Allspring Global Investments held 45,558 shares of Novo Nordisk worth $2.22M as of Q2 2026.
  • Allspring Global Investments bought 7,349 Novo Nordisk shares in Q2 2026, an estimated $316K.
  • Novo Nordisk made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1049 holding.
  • Allspring Global Investments first reported a position in Novo Nordisk in Q2 2023 and has held it in 13 quarters since.
  • Allspring Global Investments's Novo Nordisk position peaked at $50.9M in Q3 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.